These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. ACR-ASTRO Practice Parameter for the Performance of Stereotactic Body Radiation Therapy. Chao ST; Dad LK; Dawson LA; Desai NB; Pacella M; Rengan R; Xiao Y; Yenice KM; Rosenthal SA; Hartford A Am J Clin Oncol; 2020 Aug; 43(8):545-552. PubMed ID: 32404596 [TBL] [Abstract][Full Text] [Related]
6. ACR Practice Parameter for the Performance of Therapy With Unsealed Radiopharmaceutical Sources. Spratt DE; Zaki BI; Franc BL; Hartford AC; Osborne JR Clin Nucl Med; 2016 Feb; 41(2):106-17. PubMed ID: 26646993 [TBL] [Abstract][Full Text] [Related]
7. ACR-ASTRO Practice Parameter for Communication: Radiation Oncology. Schechter NR; Brown DW; Bovi JA; Dominello MM; Liu AK; Mattes MD; Michalski JM; Shih HA; Strom E; Wilkinson JB; Rosenthal SA; Hartford A Am J Clin Oncol; 2020 Aug; 43(8):553-558. PubMed ID: 32520791 [TBL] [Abstract][Full Text] [Related]
8. ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy. Love C; Desai NB; Abraham T; Banks KP; Bodei L; Boike T; Brown RKJ; Bushnell DL; DeBlanche LE; Dominello MM; Francis T; Grady EC; Hobbs RF; Hope TA; Kempf JS; Pryma DA; Rule W; Savir-Baruch B; Sethi I; Subramaniam RM; Xiao Y; Schechter NR Am J Clin Oncol; 2022 Jun; 45(6):233-242. PubMed ID: 35507413 [TBL] [Abstract][Full Text] [Related]
9. ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy. Love C; Desai NB; Abraham T; Banks KP; Bodei L; Boike T; Brown RKJ; Bushnell DL; DeBlanche LE; Dominello MM; Francis T; Grady EC; Hobbs RF; Hope TA; Kempf JS; Pryma DA; Rule W; Savir-Baruch B; Sethi I; Subramaniam RM; Xiao Y; Schechter NR Clin Nucl Med; 2022 Jun; 47(6):503-511. PubMed ID: 35507433 [TBL] [Abstract][Full Text] [Related]
10. ACR-ARS Practice Parameter for the Performance of Proton Beam Therapy. Frank SJ; Das IJ; Simone CB; Davis BJ; Deville C; Liao Z; Lo SS; McGovern SL; Parikh RR; Reilly M; Small W; Schechter NR Int J Part Ther; 2024 Sep; 13():100021. PubMed ID: 39347377 [TBL] [Abstract][Full Text] [Related]
11. ACR-ARS Practice Parameter for Communication: Radiation Oncology. Saeed H; Wallner PE; Bates JE; Chundury A; Freedman LM; Mitin T; Walker GV; Small W; Schechter NR Am J Clin Oncol; 2024 May; 47(5):210-216. PubMed ID: 38149838 [TBL] [Abstract][Full Text] [Related]
12. ACR-ARS Practice Parameter for Radiation Oncology. Lo S; Chao S; Harris E; Knisely J; Luh JY; Mohindra P; Quang TS; Ye J; Small W; Schechter NR Am J Clin Oncol; 2024 May; 47(5):201-209. PubMed ID: 38153244 [TBL] [Abstract][Full Text] [Related]
13. ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer. Bittner NHJ; Cox BW; Davis B; King M; Lawton CAF; Merrick GS; Orio P; Ouhib Z; Rossi P; Showalter T; Small W; Schechter NR Am J Clin Oncol; 2022 Jun; 45(6):249-257. PubMed ID: 35588224 [TBL] [Abstract][Full Text] [Related]
14. ACR-ABS-ASTRO Practice Parameter for the Performance of Low-Dose-Rate Brachytherapy. Woodhouse KD; Devlin PM; Kollmeier M; Lin LL; Orio P; Ouhib Z; Song D; Viswanathan AN; Watanabe Y; Yu Y; Small W; Schechter NR Am J Clin Oncol; 2022 Jun; 45(6):243-248. PubMed ID: 35485607 [TBL] [Abstract][Full Text] [Related]
15. ACR-ARS Practice Parameter for the Performance of Total Body Irradiation. Reilly M; Dandapani SV; Kumar KA; Constine L; Fogh SE; Roberts KB; Small W; Schechter NR Am J Clin Oncol; 2023 May; 46(5):185-192. PubMed ID: 36907934 [TBL] [Abstract][Full Text] [Related]
16. ACR-ASTRO practice guideline for the performance of therapy with unsealed radiopharmaceutical sources. Henkin RE; Del Rowe JD; Grigsby PW; Hartford AC; Jadvar H; Macklis RM; Parker JA; Wong JY; Rosenthal SA Clin Nucl Med; 2011 Aug; 36(8):e72-80. PubMed ID: 21716005 [TBL] [Abstract][Full Text] [Related]
19. ACR-ARS Practice Parameter on Informed Consent Radiation Oncology. Hurwitz MD; Chundury A; Goodman CR; Jones J; Lo SS; Saeed H; Small W; Schechter NR Am J Clin Oncol; 2023 Jun; 46(6):231-235. PubMed ID: 36882916 [TBL] [Abstract][Full Text] [Related]
20. Radium-223 dichloride: a novel treatment option for castration-resistant prostate cancer patients with symptomatic bone metastases. McGann S; Horton ER Ann Pharmacother; 2015 Apr; 49(4):469-76. PubMed ID: 25573268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]